Retractable Technologies (NYSE:RVP) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVPFree Report) in a report released on Tuesday. The brokerage issued a hold rating on the stock.

Retractable Technologies Stock Performance

RVP stock opened at $0.72 on Tuesday. The business’s 50-day moving average price is $0.79 and its two-hundred day moving average price is $0.75. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. The firm has a market cap of $21.67 million, a PE ratio of -1.34 and a beta of 2.08. Retractable Technologies has a 1-year low of $0.56 and a 1-year high of $1.24.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Retractable Technologies stock. Renaissance Technologies LLC boosted its holdings in shares of Retractable Technologies, Inc. (NYSE:RVPFree Report) by 9.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 361,253 shares of the company’s stock after acquiring an additional 31,140 shares during the period. Renaissance Technologies LLC owned approximately 1.21% of Retractable Technologies worth $249,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 7.58% of the company’s stock.

Retractable Technologies Company Profile

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

See Also

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.